|

PAS-004 Tablets Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 2

Top Sponsors

  • Pasithea Therapeutics Corp.2

Indications

  • NF1 Mutation2
  • Cancer2
  • Neurofibromatosis Type 1 (NF1)1
  • Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)1
  • Neurofibroma, Plexiform1

Birmingham, Alabama1 trial

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas

University of Alabama at Birmingham

Phase 1

Austin, Texas1 trial

PAS-004 in Patients With Advanced Solid Tumors

NEXT Oncology

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.